{
    "Trade/Device Name(s)": [
        "Acro Rapid Methamphetamine Urine Test"
    ],
    "Submitter Information": "Acro Biotech LLC",
    "510(k) Number": "k053033",
    "Predicate Device Reference 510(k) Number(s)": [],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DJC"
    ],
    "Summary Letter Date": "June 6, 2006",
    "Summary Letter Received Date": "April 10, 2006",
    "Submission Date": "April 10, 2006",
    "Regulation Number(s)": [
        "21 CFR\u00a7862.3610"
    ],
    "Regulation Name(s)": [
        "Methamphetamine test system"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Methamphetamine"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Lateral flow",
        "Rapid immunoassay"
    ],
    "Methodologies": [
        "Qualitative detection"
    ],
    "Submission Type(s)": [
        "Assay"
    ],
    "Document Summary": "FDA 510(k) summary for Acro Rapid Methamphetamine Urine Test lateral flow immunoassay for detection of methamphetamine in urine",
    "Indications for Use Summary": "Qualitative detection of methamphetamine in human urine at a cutoff of 500 ng/mL, for laboratory use only; provides preliminary results to be confirmed by more specific chemical method such as GC/MS",
    "fda_folder": "Toxicology"
}